Oncotype DX for Comprehensive Treatment in Male Breast Cancer: A Case Report and Literature Review

被引：2
作者：
Zheng, Ang [1 ]
Zhang, Lin [2 ]
Ji, Ziyao [3 ]
Fan, Lijuan [1 ]
Jin, Feng [1 ]
机构：
[1] China Med Univ, Affiliated Hosp 1, Dept Breast Surg, 155 Nanjing Rd, Shenyang 110001, Liaoning, Peoples R China
[2] Univ Chinese Acad Sci, NingBo Huamei Hosp, Beijing, Peoples R China
[3] China Med Univ, Affiliated Hosp 1, Dept Ultrasound, Shenyang, Liaoning, Peoples R China
来源：
AMERICAN JOURNAL OF MENS HEALTH | 2019年 / 13卷 / 03期
基金：
中国国家自然科学基金;
关键词：
male breast cancer; oncotype DX; endocrine therapy; treatment; GENE-EXPRESSION; TAMOXIFEN; RECURRENCE; PREDICTION; MANAGEMENT; PROGNOSIS; ASSAY;
D O I：
10.1177/1557988319847856
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Male breast cancer (MBC) is uncommon in clinical practice. Using the 21-gene assay to facilitate decision-making on comprehensive treatment of MBC is rarely reported. This study reports the case of a 53-year-old man with left breast cancer. Modified radical mastectomy was performed. Endocrine treatment was chosen for the patient according to the result of the 21-gene assay, a recommended genomic test of breast cancer. The patient remained in good health without evidence of recurrence at 18-month follow-up. This case provides a reference mode for the comprehensive management of early-stage, estrogen receptor-expressing and lymph node-negative MBC patients.
引用
收藏
页数：7
相关论文
共 50 条
[41]   Male breast cancer and mantle cell lymphoma in a single patient A case report and literature review [J].
Liu, Jun ;
Wei, Hongquan ;
Zhu, Keqing ;
Lai, Liqin ;
Han, Xiaoyu ;
Yang, Yue .
MEDICINE, 2017, 96 (48)
[42]   Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature [J].
Zhang, Le ;
Zhang, Chenghua ;
Yang, Zhaoying ;
He, Miao ;
Zhang, Lijuan ;
Ezzat, Shereen ;
Liang, Xi .
ONCOTARGETS AND THERAPY, 2017, 10 :5459-5462
[43]   Intracystic papillary carcinoma in a male as a rare presentation of breast cancer: A case report and literature review [J].
Romics Jr. L. ;
O'Brien M.E. ;
Relihan N. ;
O'Connell F. ;
Redmond H.P. .
Journal of Medical Case Reports, 3 (1)
[44]   Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer [J].
Karsten, Maria ;
Stempel, Michelle ;
Radosa, Julia ;
Patil, Sujata ;
King, Tari A. .
ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (02) :471-476
[45]   Predicting Chemotherapy Benefit across Different Races in Early-Stage Breast Cancer Patients Using the Oncotype DX Score [J].
Shaw, Vikram R. ;
Amos, Christopher I. ;
Cheng, Chao .
CANCERS, 2023, 15 (12)
[46]   Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer [J].
Shibata, Akio ;
Tamura, Nobuko ;
Kinowaki, Keiichi ;
Nishikawa, Aya ;
Tanaka, Kiyo ;
Kobayashi, Yoko ;
Ogura, Takuya ;
Tanabe, Yuko ;
Kawabata, Hidetaka .
BREAST CANCER, 2024, 31 (06) :1018-1027
[47]   Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer [J].
Dodson, Andrew ;
Okonji, David ;
Assersohn, Laura ;
Rigg, Anne ;
Sheri, Amna ;
Turner, Nick ;
Smith, Ian ;
Parton, Marina ;
Dowsett, Mitch .
BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) :249-258
[48]   ER and PR Immunohistochemistry and HER2 FISH versus Oncotype DX: Implications for Breast Cancer Treatment [J].
Park, MiHee M. ;
Ebel, Joshua J. ;
Zhao, Weiquiang ;
Zynger, Debra L. .
BREAST JOURNAL, 2014, 20 (01) :37-45
[49]   Challenges and barriers for the adoption of personalized medicine in Europe: the case of Oncotype DX Breast Recurrence Score® test [J].
Horgan, Denis ;
Hofman, Paul ;
Giacomini, Patrizio ;
Dube, France ;
Singh, Jaya ;
Schneider, Daniel ;
Hills, Tanya ;
Faikish, Jennifer ;
van den Bulcke, Marc ;
Malapelle, Umberto ;
Gajewski, Maciej ;
Subbiah, Vivek .
DIAGNOSIS, 2024,
[50]   Carcinosarcoma of the Pancreas Case Report With Comprehensive Literature Review [J].
Ruess, Dietrich A. ;
Kayser, Claudia ;
Neubauer, Jakob ;
Fichtner-Feigl, Stefan ;
Hopt, Ulrich T. ;
Wittel, Uwe A. .
PANCREAS, 2017, 46 (09) :1225-1233
12345